Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Vericiguat in HFrEF Patients With Coexisting Severe Tricuspid Regurgitation and Right Heart Failure; Multicenter Pragmatic Randomized Controlled Trial

NCT07668739 is registered in ClinicalTrials.gov with Daejeon St. Mary's hospital as lead sponsor.

NCT NCT07668739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07668739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Vericiguat in HFrEF Patients With Coexisting Severe Tricuspid Regurgitation and Right Heart Failure; Multicenter Pragmatic Randomized Controlled Trial
Lead sponsor
Daejeon St. Mary's hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
May 31, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hfref, tricuspid regurgitation (tr)